Important note: Information in this article was accurate in 2001. The state of the art may have changed since the publication date.
|
|
Toronto Star (12.16.01) - Friday, December 21, 2001
Prithi Yelaja
MacDonald has just returned from Kenya, where she spends three months every year studying a group of sex workers and children of HIV-infected mothers, investigating the precise mechanisms that give them greater resistance to the virus. "What we've been looking at are factors that predict immunity to HIV in human populations - trying to understand what Mother Nature is trying to tell us from exposed, uninfected people and attempting to apply that in vaccine strategies," said MacDonald, who is a microbiologist and infectious disease specialist. MacDonald and her team discovered that some of the Nairobi prostitutes remain HIV-negative despite repeated exposure to the virus.
In a widely cited study, MacDonald and her colleagues also examined HIV transmission from infected mothers to the fetus in utero. They found the risk of HIV transmission was seven times greater if the baby's human leukocyte antigen (HLA) was a perfect match with the mother's HLA than if it was different. From those studies, MacDonald and her team have developed an HIV vaccine based on HLA that they are testing in monkeys and mice. MacDonald and her team are also doing a follow-up study of those African babies who did not get AIDS from their mothers to determine whether they have any other attributes that are important for protection against HIV.
011221
AD012220
Copyright © 2001 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.